This correlation was found as well in a small study in patients with metastatic HER2 negative breast cancer undergoing capecitabine chemotherapy, reporting longer progression free survival in those with higher fecal levels of Blautia obeum and shorter in those with higher levels of Slackia. This evidence concerns the gene ERBB2 and breast cancer.